Skip to main content

Breo Ellipta News

FDA Medwatch Alert: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

ISSUE: FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large...

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single i...

FDA Approves Breo Ellipta (fluticasone furoate/vilanterol) for Asthma

London, UK, and South San Francisco, CA, USA, 30 April 2015 – GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease

Breo Ellipta patient information at Drugs.com